<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35416359</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1654</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Reviews in medical virology</Title><ISOAbbreviation>Rev Med Virol</ISOAbbreviation></Journal><ArticleTitle>Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach.</ArticleTitle><Pagination><StartPage>e2355</StartPage><MedlinePgn>e2355</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2355</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/rmv.2355</ELocationID><Abstract><AbstractText>In long coronavirus disease 2019 (long COVID-19), involvement of the musculoskeletal system is characterised by the persistence or appearance of symptoms such as fatigue, muscle weakness, myalgia, and decline in physical and functional performance, even at 4&#xa0;weeks after the onset of acute symptoms of COVID-19. Muscle injury biomarkers are altered during the acute phase of the disease. The cellular damage and hyperinflammatory state induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may contribute to the persistence of symptoms, hypoxaemia, mitochondrial damage, and dysregulation of the renin-angiotensin system. In addition, the occurrence of cerebrovascular diseases, involvement of the peripheral nervous system, and harmful effects of hospitalisation, such as the use of drugs, immobility, and weakness acquired in the intensive care unit, all aggravate muscle damage. Here, we review the multifactorial mechanisms of muscle tissue injury, aggravating conditions, and associated sequelae in long COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022 John Wiley &amp;amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Camilla Costa</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-4444-2770</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bichara</LastName><ForeName>Clea Nazar&#xe9; Carneiro</ForeName><Initials>CNC</Initials><Identifier Source="ORCID">0000-0002-2995-0136</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carneiro</LastName><ForeName>Francisca Regina Oliveira</ForeName><Initials>FRO</Initials><Identifier Source="ORCID">0000-0001-6735-4004</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacios</LastName><ForeName>Vera Regina da Cunha Menezes</ForeName><Initials>VRDCM</Initials><Identifier Source="ORCID">0000-0003-0300-7972</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berg</LastName><ForeName>Ana Virg&#xed;nia Soares Van den</ForeName><Initials>AVSVD</Initials><Identifier Source="ORCID">0000-0001-7428-7030</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quaresma</LastName><ForeName>Juarez Ant&#xf4;nio Sim&#xf5;es</ForeName><Initials>JAS</Initials><Identifier Source="ORCID">0000-0002-6267-9966</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magno Falc&#xe3;o</LastName><ForeName>Luiz F&#xe1;bio</ForeName><Initials>LF</Initials><Identifier Source="ORCID">0000-0001-8391-2694</Identifier><AffiliationInfo><Affiliation>Center for Biological and Health Sciences, State University of Para, Bel&#xe9;m, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Rev Med Virol</MedlineTA><NlmUniqueID>9112448</NlmUniqueID><ISSNLinking>1052-9276</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009141" MajorTopicYN="Y">Musculoskeletal System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">muscle</Keyword><Keyword MajorTopicYN="N">muscle dysfunction</Keyword><Keyword MajorTopicYN="N">muscle sequelae</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35416359</ArticleId><ArticleId IdType="pmc">PMC9111061</ArticleId><ArticleId IdType="doi">10.1002/rmv.2355</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taribagil P, Creer D, Tahir H. Long COVID syndrome. BMJ Case Rep. 2021;14:e241485. 10.1136/bcr-2020-241485</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-241485</ArticleId><ArticleId IdType="pmc">PMC8057566</ArticleId><ArticleId IdType="pubmed">33875508</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et&#xa0;al. Multiorgan impairment in low&#x2010;risk individuals with post&#x2010;COVID&#x2010;19 syndrome: a prospective, Community&#x2010;based study. BMJ Open. 2021;11:e048391. 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake T, Pauley E. Long Covid in adults discharged from UK hospitals after Covid&#x2010;19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Health Eur. 2021;8:100186. 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Inf Disp. 2021;53:737&#x2010;754. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et&#xa0;al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27(4):601&#x2010;615. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade BS, Siqueira S, Soares WRA, et&#xa0;al. Long&#x2010;COVID and post&#x2010;COVID health complications: an up&#x2010;to&#x2010;date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021;13(4):700. 10.3390/v13040700</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, et&#xa0;al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11:16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA. 2020;324:603&#x2010;605. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerahandi M, Hochman KA, Simon E, et&#xa0;al. Post&#x2010;discharge health status and symptoms in patients with severe COVID&#x2010;19. J Gen Intern Med. 2021;36:738&#x2010;745. 10.1007/s11606-020-06338-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06338-4</ArticleId><ArticleId IdType="pmc">PMC7808113</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Huang K, Jiang H, et&#xa0;al. Long&#x2010;term existence of SARS&#x2010;CoV&#x2010;2 in COVID&#x2010;19 patients: host immunity, viral virulence, and transmissibility. Virol Sin. 2020;35:793&#x2010;802. 10.1007/s12250-020-00308-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7644793</ArticleId><ArticleId IdType="pubmed">33156486</ArticleId></ArticleIdList></Reference><Reference><Citation>Koshi NA, Tagliari AP, Forleo GB, Fassini GM, Tondo C. Cardiac and arrhythmic complications in patients with COVID&#x2010;19. J Cardiovasc Electrophysiol. 2020;31:1003&#x2010;1008. 10.1111/jce.14479</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14479</ArticleId><ArticleId IdType="pmc">PMC7262150</ArticleId><ArticleId IdType="pubmed">32270559</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieczkowska K, Deutsch A, Borok J, et&#xa0;al. Telogen effluvium: a sequela of COVID&#x2010;19. Int J Dermatol. 2021;60:122&#x2010;124. 10.1111/ijd.15313</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15313</ArticleId><ArticleId IdType="pmc">PMC7753411</ArticleId><ArticleId IdType="pubmed">33226117</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et&#xa0;al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta&#x2010;analysis with comparison to the COVID&#x2010;19 pandemic. Lancet Psychiatr. 2020;7:611&#x2010;627. 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, et&#xa0;al. Postdischarge symptoms and rehabilitation needs in survivors of COVID&#x2010;19 infection: a cross&#x2010;sectional evaluation. J Med Virol. 2021;93:1013&#x2010;1022. 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et&#xa0;al. 6&#x2010;month consequences of COVID&#x2010;19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2010;232. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Paleoudis EG, Lesky&#x2010;Di Bari D, et&#xa0;al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID&#x2010;19 infection. PLoS ONE. 2020;15:e0243882. 10.1371/journal.pone.0243882</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Herck MV, Delbressine JM, et&#xa0;al. Persistent symptoms 3 months after a SARS&#x2010;CoV&#x2010;2 infection: the post&#x2010;COVID&#x2010;19 syndrome? ERJ Open Res. 2020;6:00542&#x2010;02020. 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et&#xa0;al. Clinical sequelae of COVID&#x2010;19 survivors in Wuhan, China: a single&#x2010;centre longitudinal study. Clin Microbiol&#xa0;Infect. 2021;27:89&#x2010;95. 10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan LK, Deadwiler B, Haratian A, Bolia IK, Weber AE, Petrigliano FA. Effects of COVID&#x2010;19 on the musculoskeletal system: clinician&#x2019;s guide. Orthop Res Rev. 2021;13:141&#x2010;150. 10.2147/ORR.S321884</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ORR.S321884</ArticleId><ArticleId IdType="pmc">PMC8464590</ArticleId><ArticleId IdType="pubmed">34584465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan R, McCullough D, Butler T, Heredia FP, Davies IG, Stewart C. Sarcopenia during COVID&#x2010;19 lockdown restrictions: long&#x2010;term health effects of short&#x2010;term muscle loss. Geroscience. 2020;42:1547&#x2010;1578. 10.1007/s11357-020-00272-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00272-3</ArticleId><ArticleId IdType="pmc">PMC7528158</ArticleId><ArticleId IdType="pubmed">33001410</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez A, Orozco&#x2010;Aguilar J, Achiardi O, Simon F, Cabello&#x2010;Verrugio C. SARS&#x2010;CoV&#x2010;2/Renin&#x2013;Angiotensin system: deciphering the clues for a couple with potentially harmful effects on skeletal muscle. Int J Mol Sci. 2020;21:7904. 10.3390/ijms21217904</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21217904</ArticleId><ArticleId IdType="pmc">PMC7663203</ArticleId><ArticleId IdType="pubmed">33114359</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo&#x2010;Mart&#xed;nez W, Lozada&#x2010; Mart&#xed;nez I, Escobar&#x2010;Collazos A, et&#xa0;al. Post&#x2010;COVID 19 neurological syndrome: implications for sequelae&#x2019;s treatment. J Clin Neurosci. 2021;88:219&#x2010;225. 10.1016/j.jocn.2021.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8031003</ArticleId><ArticleId IdType="pubmed">33992187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain FS, Eldeeb MA, Blackmore D, Siddiqi ZA. Guillain Barr&#xe9; syndrome and COVID&#x2010;19: possible role of the cytokine storm. Autoimmun Rev. 2020;19:102681. 10.1016/j.autrev.2020.102681</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102681</ArticleId><ArticleId IdType="pmc">PMC7577871</ArticleId><ArticleId IdType="pubmed">33099040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarzani R, Spannella F, Giulietti F, Di Pentima C, Giordano P, Giacometti A. Possible harm from glucocorticoid drugs misuse in the early phase of SARS&#x2010;CoV&#x2010;2 infection: a narrative review of the evidence. Intern Emerg Med. 2021. 10.1007/s11739-021-02860-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02860-3</ArticleId><ArticleId IdType="pmc">PMC8557262</ArticleId><ArticleId IdType="pubmed">34718937</ArticleId></ArticleIdList></Reference><Reference><Citation>English KL, Paddon&#x2010;Jones D. Protecting muscle mass and function in older adults during bed rest. Curr Opin Clin Nutr Metab Care. 2010;1:34&#x2010;39. 10.1097/MCO.0b013e328333aa66</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0b013e328333aa66</ArticleId><ArticleId IdType="pmc">PMC3276215</ArticleId><ArticleId IdType="pubmed">19898232</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser N, De Micheli A, Schonk M, et&#xa0;al. Musculoskeletal consequences of COVID&#x2010;19. J Bone Joint Surg Am. 2020;102:197&#x2010;1204. 10.2106/JBJS.20.00847</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.20.00847</ArticleId><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K, G&#x105;sowski J, Michel J, Veronese N. Post&#x2010;COVID&#x2010;19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res. 2021;33:2887&#x2010;2898. 10.1007/s40520-021-01942-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01942-8</ArticleId><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab. 2014;11(3):177&#x2010;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4269139</ArticleId><ArticleId IdType="pubmed">25568649</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso LGM, Vicente EFEC, Jr , Cilli EM, Costa&#x2010;Filho AJ. SARS&#x2010;CoV fusion peptides induce membrane surface ordering and curvature. Sci Rep. 2016;6:37131. 10.1038/srep37131</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep37131</ArticleId><ArticleId IdType="pmc">PMC5125003</ArticleId><ArticleId IdType="pubmed">27892522</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J, Kok K, Zhu Z, et&#xa0;al. Genomic characterization of the 2019 novel human&#x2010;pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect. 2020;9:221&#x2010;236. 10.1080/22221751.2020.1719902</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1719902</ArticleId><ArticleId IdType="pmc">PMC7067204</ArticleId><ArticleId IdType="pubmed">31987001</ArticleId></ArticleIdList></Reference><Reference><Citation>Riquelme C, Acu&#xf1;a MJ, Torrej&#xf3;n J, et&#xa0;al. ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. PLOS ONE. 2014;9:e93449. 10.1371/journal.pone.0093449</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093449</ArticleId><ArticleId IdType="pmc">PMC3973684</ArticleId><ArticleId IdType="pubmed">24695436</ArticleId></ArticleIdList></Reference><Reference><Citation>Motta&#x2010;Santos D, Dos Santos RAS, Qadri MOF, et&#xa0;al. Effects of ACE2 deficiency on physical performance and physiological adaptations of cardiac and skeletal muscle to exercise. Hypertens Res. 2016;39:506&#x2010;512. 10.1038/hr.2016.28</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/hr.2016.28</ArticleId><ArticleId IdType="pubmed">27053009</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordani L, He GJ, Negroni E, et&#xa0;al. High&#x2010;dimensional single&#x2010;cell cartography reveals novel skeletal muscle&#x2010;resident cell populations. Mol Cell. 2019;2:609&#x2010;621. 10.1016/j.molcel.2019.02.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.02.026</ArticleId><ArticleId IdType="pubmed">30922843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrandi PJ, Alway SE, Mohamed JS. The interaction between&#xa0;SARS&#x2010;CoV&#x2010;2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol. 2020;129:864&#x2010;867. 10.1152/japplphysiol.00321.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00321.2020</ArticleId><ArticleId IdType="pmc">PMC7832004</ArticleId><ArticleId IdType="pubmed">32673162</ArticleId></ArticleIdList></Reference><Reference><Citation>Madia F, Merico B, Primiano G, Cutuli SL, De Pascale G, Servidei S. Acute myopathic quadriplegia in patients with COVID&#x2010;19 in the intensive care unit. Neurology. 2020;95:492&#x2010;494. 10.1212/WNL.0000000000010280</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010280</ArticleId><ArticleId IdType="pubmed">32601119</ArticleId></ArticleIdList></Reference><Reference><Citation>Has&#xf6;ks&#xfc;z M, Kili&#xe7; S, Sara&#xe7; F. Coronaviruses and SARS&#x2010;COV&#x2010;2. Turk J Med Sci. 2020;50:549&#x2010;556. 10.3906/sag-2004-127</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2004-127</ArticleId><ArticleId IdType="pmc">PMC7195990</ArticleId><ArticleId IdType="pubmed">32293832</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS&#x2010;CoV&#x2010;2 spike glycoprotein. Cell. 2020;16:281&#x2010;292. 10.1016/j.cell.2020.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, MacAry PA, Ng LFP. The trinity of COVID&#x2010;19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363&#x2010;374. 10.1038/s41577-020-0311-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0311-8</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, et&#xa0;al. Clinical course and outcomes of critically ill patients with SARS&#x2010;CoV&#x2010;2 pneumonia in Wuhan, China: a single&#x2010;centered, retrospective, observational study. Lancet Respir Med.&#xa0;2020;8(5):475&#x2010;481. 10.1016/S2213-2600(20)30079-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, et&#xa0;al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061&#x2010;1069. 10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Falc&#xe3;o LFM, Pontes LS, Da Silva BGA, et&#xa0;al. The complexity of respiratory disease associated with severe acute respiratory syndrome coronavirus 2 (SARS&#x2010;CoV&#x2010;2) infection: from immunopathogenesis to respiratory therapy. Rev Med Virol. 2020:e2167. 10.1002/rmv.2167</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2167</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XH, Li TY, He ZC, et&#xa0;al. A pathological report of three COVID&#x2010;19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi = Chin J Pathol. 2020;49:411&#x2010;417. 10.3760/cma.j.cn112151-20200312-00193</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112151-20200312-00193</ArticleId><ArticleId IdType="pubmed">32172546</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early&#x2010;phase 2019 novel coronavirus (COVID&#x2010;19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700&#x2010;704. 10.1016/j.jtho.2020.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtho.2020.02.010</ArticleId><ArticleId IdType="pmc">PMC7128866</ArticleId><ArticleId IdType="pubmed">32114094</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttignol M, Pires&#x2010;Neto RC, Rossi E Silva RC, Albino MB, Dolhnikoff M, Mauad T. Airway and parenchyma immune cells in influenza A(H1N1) pdm09 viral and non&#x2010;viral diffuse alveolar damage. Respir Res. 2017;18:147. 10.1186/s12931-017-0630-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-017-0630-x</ArticleId><ArticleId IdType="pmc">PMC5543730</ArticleId><ArticleId IdType="pubmed">28774302</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins EP, Crean D. Hypoxia and inflammatory bowel disease. Microbes Infect. 2017;19:210&#x2010;221. 10.1016/j.micinf.2016.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2016.09.004</ArticleId><ArticleId IdType="pubmed">27664046</ArticleId></ArticleIdList></Reference><Reference><Citation>Preedy VR, Sugden PH. The effects of fasting or hypoxia on rates of protein synthesis in vivo in subcellular fractions of rat heart and gastrocnemius muscle. Biochem J. 1989;257:519&#x2010;527. 10.1042/bj2570519</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2570519</ArticleId><ArticleId IdType="pmc">PMC1135609</ArticleId><ArticleId IdType="pubmed">2930464</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EO, Juul NO, Ronning OW. Regulation of protein metabolism of human cells during and after acute hypoxia. Cancer Res 1986;46:4346&#x2010;4351.</Citation><ArticleIdList><ArticleId IdType="pubmed">3731092</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyfuss K, Hood D. A systematic review of p53 regulation of oxidative stress in skeletal muscle. Redox Rep. 2018;23:100&#x2010;117. 10.1080/13510002.2017.1416773</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13510002.2017.1416773</ArticleId><ArticleId IdType="pmc">PMC6748683</ArticleId><ArticleId IdType="pubmed">29298131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Wang P, Qin Z, et&#xa0;al. Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia. Redox Biol. 2021;38:101815. 10.1016/j.redox.2020.101815C</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101815C</ArticleId><ArticleId IdType="pmc">PMC7718484</ArticleId><ArticleId IdType="pubmed">33278780</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun Z, Qun L, Giaccia A. Adaptive myogenesis under hypoxia. Mol Cell Biol. 2005;25:3040&#x2010;3055. 10.1128/MCB.25.8.3040-3055.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.8.3040-3055.2005</ArticleId><ArticleId IdType="pmc">PMC1069592</ArticleId><ArticleId IdType="pubmed">15798192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason S, Johnson RS. The role of HIF&#x2010;1 in hypoxic response in the skeletal muscle. In: Roach RC, Wagner PD, Hackett PH (eds). Hypoxia and the Circulation. Advances in Experimental Medicine and Biology . Springer;618. 10.1007/978-0-387-75434-5_18</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-0-387-75434-5_18</ArticleId><ArticleId IdType="pubmed">18269201</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle&#x2010;Tenney R, Rebolledo D, Acu&#xf1;a MJ, et&#xa0;al. HIF&#x2010;hypoxia signaling in skeletal muscle physiology and fibrosis. J. Cell Commun. Signal. 2020;14:147&#x2010;158. 10.1007/s12079-020-00553-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12079-020-00553-8</ArticleId><ArticleId IdType="pmc">PMC7272527</ArticleId><ArticleId IdType="pubmed">32088838</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T, Dziurla R, Tripmacher R, Burmester GR, Buttgereit F. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do. Ann Rheum Dis. 2005;64:971&#x2010;980. 10.1136/ard.2004.031641</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2004.031641</ArticleId><ArticleId IdType="pmc">PMC1755583</ArticleId><ArticleId IdType="pubmed">15800008</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo A, De Mori R, Martelli F, Pompilio G, Capogrossi MC, Germani A. Hypoxia inhibits myogenic differentiation through accelerated MyoD degradation. J Biol Chem. 2004;279:16332&#x2010;16338. 10.1074/jbc.M313931200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M313931200</ArticleId><ArticleId IdType="pubmed">14754880</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Liu W, Liu Z, Longo C, Liu X, Kuang S. Hypoxia inhibits myogenic differentiation through p53 protein&#x2010;dependent induction of Bhlhe40 protein. J Biol Chem. 2015;290:29707&#x2010;29716. 10.1074/jbc.M115.688671</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.688671</ArticleId><ArticleId IdType="pmc">PMC4706003</ArticleId><ArticleId IdType="pubmed">26468276</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, Joseph P, Heerdt PM, et&#xa0;al. Persistent exertional intolerance after COVID&#x2010;19: insights from invasive cardiopulmonary exercise testing. Chest. 2021;161:54&#x2010;63. 10.1016/j.chest.2021.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Faini A, et&#xa0;al. Impact of COVID&#x2010;19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130:1470&#x2010;1478. 10.1152/japplphysiol.00710.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00710.2020</ArticleId><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA. Neurological complications of COVID&#x2010;19: underlying mechanisms and management. Int J Mol Sci. 2021;22:4081. 10.3390/ijms22084081</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22084081</ArticleId><ArticleId IdType="pmc">PMC8071289</ArticleId><ArticleId IdType="pubmed">33920904</ArticleId></ArticleIdList></Reference><Reference><Citation>Das G, Mukherjee N, Ghosh S. Neurological insights of COVID&#x2010;19 pandemic. ACS Chem Neurosci. 2020;11:1206&#x2010;1209. 10.1021/acschemneuro.0c00201</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00201</ArticleId><ArticleId IdType="pubmed">32320211</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et&#xa0;al. Evolution of antibody immunity to SARS&#x2010;CoV&#x2010;2. Nature. 2021;591:639&#x2010;644. 10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley TJ, Mocco J, Majidi S, et&#xa0;al. Large&#x2010;vessel stroke as a presenting feature of covid&#x2010;19 in the young. N Engl J Med. 2020;382:e60. 10.1056/NEJMc2009787</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia AO, Feitosa PWG, Moreira JLS, Nogueira SAR, Fonseca RB, Nobre MEP. Neurological manifestations of COVID&#x2010;19 and other coronaviruses: a systematic review. Neurol Psychiatr Brain Res. 2020;37:27&#x2010;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261450</ArticleId><ArticleId IdType="pubmed">32834527</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne T, Crewther SG, Sales C, Karimi L. COVID&#x2010;19 pathophysiology predicts that ischemic stroke occurrence is an expectation, not an exception&#x2014;a systematic review. Front Neurol. 2021;11:607221. 10.3389/fneur.2020.607221</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.607221</ArticleId><ArticleId IdType="pmc">PMC7876298</ArticleId><ArticleId IdType="pubmed">33584506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraiman P, Junior CG, Moro E, Cavallieri F, Zedde M. COVID&#x2010;19 and cerebrovascular diseases: a systematic review and perspectives for stroke management. Front Neurol. 2020;11:574694. 10.3389/fneur.2020.574694</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.574694</ArticleId><ArticleId IdType="pmc">PMC7674955</ArticleId><ArticleId IdType="pubmed">33250845</ArticleId></ArticleIdList></Reference><Reference><Citation>Trejo&#x2010;Gabriel&#x2010;Gal&#xe1;n JM. Ictus como complicaci&#xf3;n y como factor pron&#xf3;stico de COVID&#x2010;19. Neurologia. 2020;35:318&#x2010;322. 10.1016/j.nrl.2020.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2020.04.015</ArticleId><ArticleId IdType="pmc">PMC7200328</ArticleId><ArticleId IdType="pubmed">32493597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium infection and dysregulation by SARS&#x2010;CoV&#x2010;2: evidence and caveats in&#xa0;COVID&#x2010;19. Viruses. 2021;13:29. 10.3390/v13010029</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010029</ArticleId><ArticleId IdType="pmc">PMC7823949</ArticleId><ArticleId IdType="pubmed">33375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yachou Y, El Idrissi A, Belapasov V, Benali AS. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS&#x2010;CoV&#x2010;2: understanding the neurological manifestations in COVID&#x2010;19 patients. Neurol Sci. 2020;41:2657&#x2010;2669. 10.1007/s10072-020-04575-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04575-3</ArticleId><ArticleId IdType="pmc">PMC7385206</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosking MP, Lane TE. The role of chemokines during viral infection of the CNS. PLOS Pathog. 2010;6:e1000937. 10.1371/journal.ppat.1000937</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000937</ArticleId><ArticleId IdType="pmc">PMC2912390</ArticleId><ArticleId IdType="pubmed">20686655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Kream RM, Stefano GB. Long&#x2010;term respiratory and neurological sequelae of COVID&#x2010;19. Med Sci Mon Int Med J Exp Clin Res. 2020;26:e928996. 10.12659/MSM.928996</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Shen D, Zhou H, Liu J. Guillain&#x2010;Barr&#xe9; syndrome associated with SARS&#x2010;CoV&#x2010;2 infection: causality or coincidence? Lancet Neurol.&#xa0;2020;19:383&#x2010;384. 10.1016/S1474-4422(20)30109-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker A, Anson M, Harky A. Neurological Manifestations of COVID&#x2010;19: a systematic review and current update. Acta Neurol Scand. 2020;142:14&#x2010;22. 10.1111/ane.13266</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13266</ArticleId><ArticleId IdType="pmc">PMC7273036</ArticleId><ArticleId IdType="pubmed">32412088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan AS, Ivey FM, Prior S, Li G, Hafer&#x2010;Macko G. Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors. Stroke. 2011;42:416&#x2010;420. 10.1161/STROKEAHA.110.602441</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.110.602441</ArticleId><ArticleId IdType="pmc">PMC3026882</ArticleId><ArticleId IdType="pubmed">21164115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingraham NE, Barakat AG, Reilkoff R, et&#xa0;al. Understanding the renin&#x2013;angiotensin&#x2013;aldosterone&#x2013;SARS&#x2010;CoV axis: a comprehensive review. Eur Respir J. 2020;56:2000912. 10.1183/13993003.00912-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00912-2020</ArticleId><ArticleId IdType="pmc">PMC7236830</ArticleId><ArticleId IdType="pubmed">32341103</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz EDC, Prodel E, Braz ID, et&#xa0;al. Modulation of the renin&#x2013;angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training. Clin Sci (Lond). 2018;132:1487&#x2010;1507. 10.1042/CS20180276</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180276</ArticleId><ArticleId IdType="pubmed">30037837</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabello&#x2010;Verrugio C, Cordova G, Salas JD. Angiotensin II: role in skeletal muscle atrophy. Curr Protein Pept Sci. 2012;13:560&#x2010;569. 10.2174/138920312803582933</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920312803582933</ArticleId><ArticleId IdType="pubmed">22974090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabello&#x2010;Verrugio C, Morales MG, Rivera JC, Cabrera D, Simon F. Renin&#x2010;angiotensin system: an old player with novel functions in skeletal muscle. Med Res Ver. 2015;35:437&#x2010;463. 10.1002/med.21343</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21343</ArticleId><ArticleId IdType="pubmed">25764065</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a LF. Immune response, inflammation, and the clinical spectrum of COVID&#x2010;19. Front Immunol. 2020;11:1441. 10.3389/fimmu.2020.01441</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01441</ArticleId><ArticleId IdType="pmc">PMC7308593</ArticleId><ArticleId IdType="pubmed">32612615</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long road toward COVID&#x2010;19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11:1817. 10.3389/fimmu.2020.01817</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01817</ArticleId><ArticleId IdType="pmc">PMC7385234</ArticleId><ArticleId IdType="pubmed">32793245</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Li H, Fan R, et&#xa0;al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2016;59:163&#x2010;169. 10.1159/000453066</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000453066</ArticleId><ArticleId IdType="pmc">PMC7179523</ArticleId><ArticleId IdType="pubmed">28103598</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et&#xa0;al. Pathological findings of COVID&#x2010;19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420&#x2010;422. 10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et&#xa0;al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2010;506. 10.1016/S0140-6736(20)30183-82</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-82</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai C&#x2010;L. Long COVID&#x2010;19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. 2021;9:966. 10.3390/biomedicines9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson JA, Baltgalvis KA. Interleukin&#x2010;6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev. 2010;38:168&#x2010;176. 10.1097/JES.0b013e3181f44f11</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JES.0b013e3181f44f11</ArticleId><ArticleId IdType="pmc">PMC3065300</ArticleId><ArticleId IdType="pubmed">20871233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao S, Durstine JL, Koh H&#x2010;J, Carver WE, Frizzel N, Carson JA. Acute myotube protein synthesis regulation by IL&#x2010;6&#x2010;related cytokines. Am J Physiol Cell Physiol. 2017;313:C487&#x2010;C500. 10.1152/ajpcell.00112.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00112.2017</ArticleId><ArticleId IdType="pmc">PMC5792171</ArticleId><ArticleId IdType="pubmed">28768641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz&#x2010;C&#xe1;noves P, Scheele C, Pedersen BK, Serrano AL. Interleukin&#x2010;6 myokine signaling in skeletal muscle: a double&#x2010;edged sword? FEBS J. 2013;280:4131&#x2010;4148. 10.1111/febs.12338</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12338</ArticleId><ArticleId IdType="pmc">PMC4163639</ArticleId><ArticleId IdType="pubmed">23663276</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerci A, Lahoute C, H&#xe9;brad S, et&#xa0;al. Srf&#x2010;dependent paracrine signals produced by myofibers control satellite cell&#x2010;mediated skeletal muscle hypertrophy. Cell Metab 2012;15:25&#x2010;37. 10.1016/j.cmet.2011.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.12.001</ArticleId><ArticleId IdType="pubmed">22225874</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderVeen BN, Fix DK, Montalvo RN, Counts BR, Smuder AJ. The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated IL&#x2010;6. Exp Physiol. 2019;104:385&#x2010;397. 10.1113/EP087429</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP087429</ArticleId><ArticleId IdType="pmc">PMC6750733</ArticleId><ArticleId IdType="pubmed">30576589</ArticleId></ArticleIdList></Reference><Reference><Citation>White JP, Puppa MJ, Sato S, et&#xa0;al. IL&#x2010;6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc Min/+ mouse. Skeletl Muscle. 2012;2:14. 10.1186/2044-5040-2-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2044-5040-2-14</ArticleId><ArticleId IdType="pmc">PMC3431229</ArticleId><ArticleId IdType="pubmed">22769563</ArticleId></ArticleIdList></Reference><Reference><Citation>Broussard SR, McCusker RH, Novakofski JE, et&#xa0;al. IL&#x2010;1&#x3b2; impairs insulin&#x2010;like growth factor I&#x2010;induced differentiation and downstream activation signals of the insulin&#x2010;like growth factor I receptor in myoblasts. J Immunol. 2004;172:7713&#x2010;7720. 10.4049/jimmunol.172.12.7713</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.172.12.7713</ArticleId><ArticleId IdType="pubmed">15187154</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooney RNR, Shumate M. The inhibitory effects of interleukin&#x2010;1 on growth hormone action during catabolic illness. Vitam Horm.&#xa0;2006;74:317&#x2010;340. 10.1016/S0083-6729(06)74013-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0083-6729(06)74013-4</ArticleId><ArticleId IdType="pubmed">17027521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang CH, Frost RA, Nairn AC, MacLean D, Vary TC. TNF&#x2010;&#x3b1; impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab. 2002;282:E336&#x2010;E347. 10.1152/ajpendo.00366.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00366.2001</ArticleId><ArticleId IdType="pubmed">11788365</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardim BJ, Campbell KS, Smith JD, et&#xa0;al. TNF&#x2010;&#x3b1; acts via TNFR1 and muscle&#x2010;derived oxidants to depress myofibrillar force in murine skeletal muscle. J Appl Physiol. 2008;104:694&#x2010;699. 10.1152/japplphysiol.00898.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00898.2007</ArticleId><ArticleId IdType="pubmed">18187611</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar S, Panguluri SK, Gupta SK, Dahiya S, Lundy RF, Kumar A. Tumor necrosis factor&#x2010;&#x3b1; regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLOS ONE. 2010;5:e13262. 10.1371/journal.pone.0013262</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013262</ArticleId><ArticleId IdType="pmc">PMC2953497</ArticleId><ArticleId IdType="pubmed">20967264</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackman RW, Cornwell EW, Wu C, Kandarian SC. Nuclear factor&#x2010;&#x3ba;B signalling and transcriptional regulation in skeletal muscle atrophy. Exp Physiol. 2013;98:19&#x2010;24. 10.1113/expphysiol.2011.063321</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2011.063321</ArticleId><ArticleId IdType="pmc">PMC3505235</ArticleId><ArticleId IdType="pubmed">22848079</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid MB, L&#xe4;nnergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor&#x2010;alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med. 2002;166:479&#x2010;484. 10.1164/rccm.2202005</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.2202005</ArticleId><ArticleId IdType="pubmed">12186824</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID&#x2010;19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269&#x2010;270. 10.1038/s41577-020-0308-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0308-3</ArticleId><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Xu X, Chen Z, et&#xa0;al. Nervous system involvement after infection with COVID&#x2010;19 and other coronaviruses. Brain Behav Immun. 2020;87:18&#x2010;22. 10.1016/j.bbi.2020.03.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T, Schneider J, Greuel S, et&#xa0;al. Association between SARS&#x2010;CoV&#x2010;2 infection and immune&#x2010;mediated myopathy in patients who have died JAMA Neurol 2021;78:948&#x2010;960. 10.1001/jamaneurol.2021.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2004</ArticleId><ArticleId IdType="pubmed">34115106</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzetti E, Calvani R, Cesari M, et&#xa0;al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol. 2013;45:2288&#x2010;2301. 10.1016/j.biocel.2013.06.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2013.06.024</ArticleId><ArticleId IdType="pmc">PMC3759621</ArticleId><ArticleId IdType="pubmed">23845738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatti JS, Bhatti GK, Reddy H. Mitochondrial dysfunction and oxidative stress in metabolic disorders&#x2014;a step towards mitochondria based therapeutic strategies. Biochim Biophys Acta (BBA)&#x2014;Mol Basis Dis. 2017;1863:1066&#x2010;1077. 10.1016/j.bbadis.2016.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.11.010</ArticleId><ArticleId IdType="pmc">PMC5423868</ArticleId><ArticleId IdType="pubmed">27836629</ArticleId></ArticleIdList></Reference><Reference><Citation>Boengler K, Kosiol M, Mayr M, Schulz R, Rohrbach S. Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue. J Cachexia, Sarcopenia Muscle 2017;8:349&#x2010;369. 10.1002/jcsm.12178</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12178</ArticleId><ArticleId IdType="pmc">PMC5476857</ArticleId><ArticleId IdType="pubmed">28432755</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen AM, Patel SP, Smith JD, et&#xa0;al. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model. Elife. 2019;3:e49920. 10.7554/eLife.49920</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.49920</ArticleId><ArticleId IdType="pmc">PMC6890461</ArticleId><ArticleId IdType="pubmed">31793435</ArticleId></ArticleIdList></Reference><Reference><Citation>Schefold JC, Bierbrauer J, Weber&#x2010;Carstens S. Intensive care unit&#x2014;acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010;1:147&#x2010;157. 10.1007/s13539-010-0010-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13539-010-0010-6</ArticleId><ArticleId IdType="pmc">PMC3060654</ArticleId><ArticleId IdType="pubmed">21475702</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer KP, Bastin MLT, Montgomery&#x2010;Yates A, et&#xa0;al. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit Care. 2020;24:637. 10.1186/s13054-020-03355-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03355-x</ArticleId><ArticleId IdType="pmc">PMC7640401</ArticleId><ArticleId IdType="pubmed">33148301</ArticleId></ArticleIdList></Reference><Reference><Citation>De Letter MACJ, Doorn PA van, SavelKoul HFJ, et&#xa0;al. Critical illness polynauropathy and myopathy (CIPNM): evidence for local immune activation by cytokine&#x2010;expression in the muscle tissue. J Neuroimmunol. 2000;106:206&#x2010;213. 10.1016/s0165-5728(99)00252-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0165-5728(99)00252-0</ArticleId><ArticleId IdType="pubmed">10814799</ArticleId></ArticleIdList></Reference><Reference><Citation>Witteveen E, Wieske L, Verhamme C, Schultz MJ, Schaik IN, Horn J. Muscle and nerve inflammation in intensive care unit&#x2010;acquired weakness: a systematic translational review. J Neurol Sci. 2014;345:15&#x2010;25. 10.1016/j.jns.2014.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.07.014</ArticleId><ArticleId IdType="pubmed">25128472</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005;32:140&#x2010;163. 10.1002/mus.20304</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20304</ArticleId><ArticleId IdType="pubmed">15825186</ArticleId></ArticleIdList></Reference><Reference><Citation>C&#xe1;mara&#x2010;Lemarroy CR, Guzm&#xe1;n&#x2010;de la Garza FJ, Fern&#xe1;ndez&#x2010;Garza NE. Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. Neuroimmunomodulation. 2010;17:314&#x2010;324. 10.1159/000292020</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000292020</ArticleId><ArticleId IdType="pubmed">20407283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274. 10.1186/s13054-015-0993-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0993-7</ArticleId><ArticleId IdType="pmc">PMC4526175</ArticleId><ArticleId IdType="pubmed">26242743</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011;10:931&#x2010;941. 10.1016/S1474-4422(11)70178-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70178-8</ArticleId><ArticleId IdType="pubmed">21939902</ArticleId></ArticleIdList></Reference><Reference><Citation>Batt J, Dos Santos CC, Cameron JI, Herridge MS. Intensive care unit&#x2013;acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med. 2013;187:238&#x2010;246. 10.1164/rccm.201205-0954SO</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201205-0954SO</ArticleId><ArticleId IdType="pubmed">23204256</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, et&#xa0;al. Dexamethasone in hospitalized patients with covid&#x2010;19. N Engl J Med. 2021;25:693&#x2010;704. 10.1056/NEJMoa2021436</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomazini BM, Maia IS, Cavalcanti AB, et&#xa0;al. Effect of dexamethasone on days alive and ventilator&#x2010;free in patients with moderate or severe acute respiratory distress syndrome and COVID&#x2010;19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307&#x2010;1316. 10.1001/jama.2020.1702</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1702</ArticleId><ArticleId IdType="pmc">PMC7489411</ArticleId><ArticleId IdType="pubmed">32876695</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirks&#x2010;Naylor AJ, Griffiths CL. Glucocorticoid&#x2010;induced apoptosis and cellular mechanisms of myopathy. J Steroid Biochem Mol Biol. 2009;117:1&#x2010;7. 10.1016/j.jsbmb.2009.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2009.05.014</ArticleId><ArticleId IdType="pubmed">19520160</ArticleId></ArticleIdList></Reference><Reference><Citation>Schakman O, Gilson H, Thissen JP. Mechanisms of glucocorticoid&#x2010;induced myopathy. J Endocrinol. 2008;197:1&#x2010;10. 10.1677/JOE-07-0606</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/JOE-07-0606</ArticleId><ArticleId IdType="pubmed">18372227</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Gupta Y. Glucocorticoid&#x2010;induced myopathy: pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab. 2013;17:913&#x2010;916. 10.4103/2230-8210.117215</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.117215</ArticleId><ArticleId IdType="pmc">PMC3784879</ArticleId><ArticleId IdType="pubmed">24083177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TT, Beutler SS, Urman RD. Moderate and deep sedation training and pharmacology for nonanesthesiologists. Curr Opin Anaesthesiol. 2019;32:457&#x2010;463. 10.1097/aco.0000000000000758</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0000000000000758</ArticleId><ArticleId IdType="pubmed">31219870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kress JP. Sedation and mobility. Crit Care Clin. 2013;29:67&#x2010;75. 10.1016/j.ccc.2012.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2012.10.001</ArticleId><ArticleId IdType="pubmed">23182528</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Forel JM, Gacouin A, et&#xa0;al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107&#x2010;1116. 10.1056/NEJMoa1005372</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1005372</ArticleId><ArticleId IdType="pubmed">20843245</ArticleId></ArticleIdList></Reference><Reference><Citation>Segredo V, Caldwell JE, Matthay MA, et&#xa0;al. Persistent paralysis in critically ill patients after long&#x2010;term administration of vecuronium.&#xa0;N Engl J Med. 1992;327:524&#x2010;528. 10.1056/NEJM199208203270804</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199208203270804</ArticleId><ArticleId IdType="pubmed">1353252</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledowski T, Ni&#xdf;ler S, Wenk M, Pogatzki&#x2010;Zahn EM, Segelcke D. Efects of muscle relaxants on ischaemia damage in skeletal muscle.&#xa0;Sci Rep. 2018;8:5794. 10.1038/s41598-018-24127-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24127-2</ArticleId><ArticleId IdType="pmc">PMC5895809</ArticleId><ArticleId IdType="pubmed">29643396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mefford B, Donaldson JC, Bissell BD. To block or not: updates in neuromuscular blockade in acute respiratory distress syndrome. Ann Pharmacother. 2020;54:899&#x2010;906. 10.1177/1060028020910132</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028020910132</ArticleId><ArticleId IdType="pubmed">32111121</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreiro E. Models of disuse muscle atrophy: therapeutic implications in critically ill patients. Ann Transl Med. 2018;6:29. 10.21037/atm.2017.12.12</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2017.12.12</ArticleId><ArticleId IdType="pmc">PMC5799135</ArticleId><ArticleId IdType="pubmed">29430446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumien N, Shetty RA, Gonzales EB. Creatine, creatine kinase, and aging. Subcell Biochem. 2018;90:145&#x2010;168. 10.1007/978-981-13-2835-0_6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-2835-0_6</ArticleId><ArticleId IdType="pubmed">30779009</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Ver. 2008;88:287&#x2010;332. 10.1152/physrev.00015.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00015.2007</ArticleId><ArticleId IdType="pubmed">18195089</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Caram LM, Faganello MM, Sanchez FF, Tanni SE, Godoy I. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients. Int J Chronic Obstr Pulm Dis. 2015;10:1553&#x2010;1558. 10.2147/COPD.S85954</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S85954</ArticleId><ArticleId IdType="pmc">PMC4531022</ArticleId><ArticleId IdType="pubmed">26345641</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaap LA, Pluijm SMF, Deeg DJH, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:526.e9&#x2010;e17. 10.1016/j.amjmed.2005.10.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2005.10.049</ArticleId><ArticleId IdType="pubmed">16750969</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinkley TE, Leng X, Miller ME, et&#xa0;al. Chronic inflammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci. 2009;64:455&#x2010;461. 10.1093/gerona/gln038</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/gln038</ArticleId><ArticleId IdType="pmc">PMC2657165</ArticleId><ArticleId IdType="pubmed">19196644</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X, Liu L, Fu T, et&#xa0;al. Exercise inducible lactate dehydrogenase B regulates mitochondrial function in skeletal muscle. J Biol Chem. 2016;291:25306&#x2010;25318. 10.1074/jbc.M116.749424</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.749424</ArticleId><ArticleId IdType="pmc">PMC5207234</ArticleId><ArticleId IdType="pubmed">27738103</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan T, Khoo B, Mills EG, et&#xa0;al. Association between high serum total cortisol concentrations and mortality from COVID&#x2010;19. Lancet Diabetes Endocrinol. 2020;8:659&#x2010;660. 10.1016/S2213-8587(20)30216-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30216-3</ArticleId><ArticleId IdType="pmc">PMC7302794</ArticleId><ArticleId IdType="pubmed">32563278</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeters GMEE, Van Schoor NM, Van Rossum EFC, Visser M, Lips P. The relationship between cortisol, muscle mass and muscle strength in older persons and the role of genetic variations in the glucocorticoid receptor. Clin Endocrinol. 2008;69:673&#x2010;682. 10.1111/j.1365-2265.2008.03212.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2008.03212.x</ArticleId><ArticleId IdType="pubmed">18248637</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng F, Zhang L, Lyu L, et&#xa0;al. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID&#x2010;19. Med Clin. 2021;156:324&#x2010;331. 10.1016/j.medcli.2020.11.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.11.030</ArticleId><ArticleId IdType="pmc">PMC8016043</ArticleId><ArticleId IdType="pubmed">33824908</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira AC, Mesquita G, Gomes MS. Ferritin: an inflammatory player keeping iron at the core of pathogen&#x2010;host interactions. Microorganisms. 2020;8:589. 10.3390/microorganisms8040589</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8040589</ArticleId><ArticleId IdType="pmc">PMC7232436</ArticleId><ArticleId IdType="pubmed">32325688</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneroni M, Simonelli C, Saleri M, et&#xa0;al. Muscle strength and physical performance in patients without previous disabilities recovering from COVID&#x2010;19 pneumonia. Am J Phys Med Rehabil. 2021;100(2):105&#x2010;109. 10.1097/PHM.0000000000001641</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001641</ArticleId><ArticleId IdType="pubmed">33181531</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune&#x2010;metabolic viewpoint for age&#x2010;related diseases. Nat Rev Endocrinol. 2018;14(10):576&#x2010;590. 10.1038/s41574-018-0059-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-018-0059-4</ArticleId><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentson&#x2010;Lantz EJ, English KL, Paddon&#x2010;Jones D, Fry CS. Fourteen days of bed rest induces a decline in satellite cell content and robust atrophy of skeletal muscle fibers in middle&#x2010;aged adults. J Appl Physiol. 2016;120:965&#x2010;975. 10.1152/japplphysiol.00799.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00799.2015</ArticleId><ArticleId IdType="pmc">PMC4835912</ArticleId><ArticleId IdType="pubmed">26796754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilroe SP, Fulford J, Holwerda AM, et&#xa0;al. Short&#x2010;term muscle disuse induces a rapid and sustained decline in daily myofibrillar protein synthesis rates. Am J Physiol Endocrinol Metab. 2020;318:E117&#x2010;E130. 10.1152/ajpendo.00360.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00360.2019</ArticleId><ArticleId IdType="pubmed">31743039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyani RR, Corriere M, Ferrucci L. Age&#x2010;related and disease&#x2010;related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819&#x2010;829. 10.1016/S2213-8587(14)70034-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(14)70034-8</ArticleId><ArticleId IdType="pmc">PMC4156923</ArticleId><ArticleId IdType="pubmed">24731660</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. COVID's toll on smell and taste: what scientists do and don't know. Nature. 2021;589(7842):342&#x2010;343. 10.1038/d41586-021-00055-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00055-6</ArticleId><ArticleId IdType="pubmed">33452511</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantozzi PJ, Pampena E, Di Vanna D, et&#xa0;al. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID&#x2010;19. Am J Otolaryngol. 2020;41:102721. 10.1016/j.amjoto.2020.102721</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102721</ArticleId><ArticleId IdType="pmc">PMC7482593</ArticleId><ArticleId IdType="pubmed">32977063</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson C, Capewell R, Ellis S, et&#xa0;al. Dysphagia presentation and management following coronavirus disease 2019: an acute care tertiary centre experience. J Laryngol Otol. 2020;134:981&#x2010;986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683822</ArticleId><ArticleId IdType="pubmed">33168109</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post&#x2010;SARS syndrome; a case&#x2010;controlled study. BMC Neurol. 2011;11:37. 10.1186/1471-2377-11-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: post&#x2010;viral syndrome post COVID&#x2010;19. Med Hypotheses. 2020;144:110055. 10.1016/j.mehy.2020.110055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H, Patel K, Greenwood DC, et&#xa0;al. Long&#x2010;term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta&#x2010;analysis. J Rehabil Med. 2020;52:jrm00063. 10.2340/16501977-2694</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long&#x2010;term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15:543&#x2010;550. 10.1111/j.1440-1843.2010.01720.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalakis K, Ilias I. SARS&#x2010;CoV&#x2010;2 infection and obesity: common inflammatory and metabolic aspects. Diabetes Metabol Syndr. 2020;14(4):469&#x2010;471. 10.1016/j.dsx.2020.04.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.033</ArticleId><ArticleId IdType="pmc">PMC7189186</ArticleId><ArticleId IdType="pubmed">32387864</ArticleId></ArticleIdList></Reference><Reference><Citation>Demeco A, Marotta N, Barletta M, et&#xa0;al. Rehabilitation of patients post&#x2010;COVID&#x2010;19 infection: a literature review. J Int Med Res;48(8):0300060520948382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450453</ArticleId><ArticleId IdType="pubmed">32840156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney S, Webster A, Paul L. Systematic review of changes and recovery in physical function and fitness after severe acute respiratory syndrome&#x2010;related coronavirus infection: implications for COVID&#x2010;19 rehabilitation. Phys Ther. 2020;100(10):1717&#x2010;1729. 10.1093/ptj/pzaa129</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzaa129</ArticleId><ArticleId IdType="pmc">PMC7454932</ArticleId><ArticleId IdType="pubmed">32737507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high&#x2010;risk factors for severe coronavirus disease 2019 (Covid&#x2010;19). Diabetes&#xa0;Metab Res Rev. 2021;37:e3377. 10.1002/dmrr.3377</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3377</ArticleId><ArticleId IdType="pmc">PMC7361201</ArticleId><ArticleId IdType="pubmed">32588943</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>